Prostaglandin F2a tris salt Good Manufacturer supply High Quality 38562-01-5
- Molecular Formula:C20H34O5.C4H11NO3
- Molecular Weight:475.623
- Vapor Pressure:1.71E-13mmHg at 25°C
- Melting Point:25-35oC
- Boiling Point:531 °C at 760 mmHg
- Flash Point:289 °C
- PSA：184.70000
- LogP:1.40400
Prostaglandin F2a tris salt (38562-01-5) Usage
Dinoprost tromethamine is a synthetic analogue of prostaglandin. F2α is an autocrine hormone present in many mammalian tissues. It is used to cause luteolysis in the cow, sow and mare. It is given as a single injection by im or sc routes, the recommended dosage rate is 25 mg cow; 10 mg sow and 5 mg mare. It is rapidly absorbed from the injection site. It has an extremely short half life of only a few minutes, it is almost completely cleared following one or two passages through the liver and/or lungs.
How to get the best price on Prostaglandin F2a tris salt?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Prostaglandin F2a tris salt . You can buy high quality, low price Prostaglandin F2a tris salt 38562-01-5 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
